Table 2. Variation of individual nucleosides levels in the urine samples from normal controls and cancer patients.
Normal controls (n = 45) | All cancer patients (n = 104) | |||||||
Nucleosides | Ave±SD | Median | Range | Ave±SD | Median | Range | p-Value | Fold change |
Cytidine | 1.25±0.83 | 0.96 | 0.28–4.17 | 2.29±1.78 | 1.90 | 0.14–8.8 | 0.00 | 1.9 |
3-methylcytidine | 0.81±0.27 | 0.76 | 0.28–1.38 | 1.19±0.8 | 1.07 | 0.22–5.88 | 0.01 | 1.5 |
1-methyladenosine | 6.47±2.47 | 6.59 | 2.47–13.14 | 9.16±5.19 | 8.42 | 1.22–26.28 | 0.00 | 1.4 |
2-deoxyguanosine | 0.15±0.13 | 0.09 | 0.03–0.55 | 0.22±0.24 | 0.13 | 0.02–1.18 | 0.41 | 1.7 |
Adenosine | 2.07±0.87 | 1.8 | 0.75–4.11 | 3.88±2.62 | 3.31 | 0.3–15.23 | 0.00 | 1.9 |
Inosine | 0.3±0.32 | 0.21 | 0.03–1.88 | 0.64±0.77 | 0.35 | 0.04–5.02 | 0.00 | 2.0 |
Fold change calculated by average.
p-Value: Mann-Whitney U test.